Endobronchial Valves in the Management of Persistent Air Leak in Coronavirus Disease 2019.
Where this comes from
- Record sourced from PubMed, PMID 34492216.
- Also identified by DOI 10.1016/j.athoracsur.2021.08.011 and PMC identifier 8418015.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Pneumothorax and persistent air leak are documented complications of severe acute respiratory syndrome coronavirus 2 infection. Patients who fall into this category are often poor candidates for invasive thoracic surgical intervention. Endobronchial valves offer an effective and less invasive treatment option and can successfully treat persistent air leak and support the weaning of patients with severe acute respiratory syndrome coronavirus 2 pneumonia off ventilation.
Medical subject headings
- COVID-19
- Pneumothorax
- Prostheses and Implants